Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1α activation in C6 glioma cells

Journal of Pharmacy and Pharmacology

Volumn 59, Issue 6, 2007, Pages 849-856

  Huang, Xiao Jia ^a   Ma, Zhen Qiu ^a   Zhang, Wei Ping ^a   Lu, Yun Bi ^a   Wei, Er Qing ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; DIHYDROARTEMISININ; FERROUS SULFATE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; CANCER INHIBITION; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; GLIOMA CELL; IMMUNOBLOTTING; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARTEMISININS; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHELATING AGENTS; DEFEROXAMINE; FERROUS COMPOUNDS; GLIOMA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; RATS; REACTIVE OXYGEN SPECIES; SESQUITERPENES; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 34447325413     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.59.6.0011     Document Type: Article

References (41)

1. Anfosso, L., Efferth, T., Albini, A., Pfeffer, U. (2006) Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins. Pharmacogenomics J. 6: 269-278
2. Berger, T. G., Dieckmann, D., Efferth, T., Schultz, E. S., Funk, J. O., Baur, A., Schuler, G. (2005) Artesunate in the treatment of metastatic uveal melanoma-first experiences. Oncol. Rep. 14: 1599-1603
3. Blum, R., Jacob-Hirsch, J., Amariglio, N., Rechavi, G., Kloog, Y. (2005) Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death. Cancer Res. 65: 999-1006
4. Chandra, J., Hackbarth, J., Le, S., Loegering, D., Bone, N., Bruzek, L. M., Narayanan, V. L., Adjei, A. A., Kay, N. E., Tefferi, A., Karp, J. E., Sausville, E. A., Kaufmann, S. H. (2003) Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells. Blood 102: 4512-4519
5. Chen, H. H., Zhou, H. J., Fang, X. (2003) Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro. Pharmacol. Res. 48: 231-236
6. Chen, H. H., Zhou, H. J., Wu, G. D., Lou, X. E. (2004) Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1. Pharmacology 71: 1-9
7. Damert, A., Machein, M., Breier, G., Fujita, M. Q., Hanahan, D., Risau, W., Plate, K. H. (1997) Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res. 57: 3860-3864
8. D'Angelo, G., Duplan, E., Vigne, P., Frelin, C. (2003) Cyclosporin A prevents the hypoxic adaptation by activating hypoxia-inducible factor-1alpha Pro-564 hydroxylation. J. Biol. Chem. 278: 15406-15411
9. Dell'Eva, R., Pfeffer, U., Vene, R., Anfosso, L., Forlani, A., Albini, A., Efferth, T. (2004) Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate. Biochem. Pharmacol. 68: 2359-2366
10. Disbrow, G. L., Baege, A. C., Kierpiec, K. A., Yuan, H., Centeno, J. A., Thibodeaux, C. A., Hartmann, D., Schlegel, R. (2005) Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo. Cancer Res. 65: 10854-10861
11. Efferth, T. (2006) Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells. Curr. Drug Targets 7: 407-421
12. Efferth, T., Rucker, G., Falkenberg, M., Manns, D., Olbrich, A., Fabry, U., Osieka, R. (1996) Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs. Arzneimittelforschung 46: 196-200
13. Efferth, T., Dunstan, H., Sauerbrey, A., Miyachi, H., Chitambar, C. R. (2001) The anti-malarial artesunate is also active against cancer. Int. J. Oncol. 18: 767-773
14. Efferth, T., Benakis, A., Romero, M. R., Tomicic, M., Rauh, R., Steinbach, D., Hafer, R., Stamminger, T., Oesch, F., Kaina, B., Marschall, M. (2004a) Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. Free Radic. Biol. Med. 37: 998-1009
15. Efferth, T., Oesch, F. (2004b) Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines. Biochem. Pharmacol. 68: 3-10
16. Haroun, R. I., Clatterbuck, R. E., Gibbons, M. C., Burger, P. C., Parker, R., Fruehauf, J. P., Brem, H. (2002) Extreme drug resistance in primary brain tumors: in vitro analysis of 64 resection specimens. J. Neurooncol. 58: 115-123
17. Hien, T. T., White, N. J. (1993) Qinghaosu. Lancet 341: 603-608
18. Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., Semenza, G. L. (1998) Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12: 149-162
19. Jensen, R. L., Ragel, B. T., Whang, K., Gillespie, D. (2006) Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas. J. Neurooncol. 78: 233-247
20. Klayman, D. L. (1985) Qinghaosu (artemisinin): an antimalarial drug from China. Science 228: 1049-1055
21. Lai, H., Singh, N. P. (1995) Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. Cancer Lett. 91: 41-46
22. Lai, H., Singh, N. P. (2006) Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat. Cancer Lett. 231: 43-48
23. Lai, H., Sasaki, T., Singh, N. P. (2005a) Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds. Expert. Opin. Ther. Targets 9: 995-1007
24. Lai, H., Sasaki, T., Singh, N. P., Messay, A. (2005b) Effects of artemisinin-tagged holotransferrin on cancer cells. Life Sci. 76: 1267-1279
25. Lee, J., Zhou, H. J., Wu, X. H. (2006) Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells. Cancer Chemother. Pharmacol. 57: 213-220
26. Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., Ratcliffe, P. J. (1997) Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl Acad. Sci. 94: 8104-8109
27. Moore, J. C., Lai, H., Li, J. R., Ren, R. L., McDougall, J. A., Singh, N. P., Chou, C. K. (1995) Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat. Cancer Lett. 98: 83-87
28. O'Neill, P. M., Posner, G. H. (2004) A medicinal chemistry perspective on artemisinin and related endoperoxides. J. Med. Chem. 47: 2945-2964
29. Paik, I. H., Xie, S., Shapiro, T. A., Labonte, T., Narducci Sarjeant, A. A., Baege, A. C., Posner, G. H. (2006) Second generation, orally active, antimalarial, artemisinin-derived trioxane dimers with high stability, efficacy, and anticancer activity. J. Med. Chem. 49: 2731-2734
30. Semenza, G. L., Roth, P. H., Fang, H. M., Wang, G. L. (1994) Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269: 23757-23763
31. Singh, N. P., Lai, H. (2001) Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci. 70: 49-56
32. Singh, N. P., Lai, H. C. (2004) Artemisinin induces apoptosis in human cancer cells. Anticancer Res. 24: 2277-2280
33. Singh, N. P., Lai, H. C. (2005) Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells. Anticancer Res. 25: 4325-4531
34. Sobhanifar, S., Aquino-Parsons, C., Stanbridge, E. J., Olive, P. (2005) Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors. Cancer Res. 65: 7259-7266
35. Sun, X., Liu, M., Wei, Y., Liu, F., Zhi, X., Xu, R., Krissansen, G. W. (2006) Overexpression of von Hippel-Lindau tumor suppressor protein and antisense HIF-1alpha eradicates gliomas. Cancer Gene. Ther. 13: 428-435
36. Wang, G. L., Semenza, G. L. (1993) General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl Acad. Sci. 90: 4304-4308
37. Weaver, M., Laske, D. W. (2003) Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas. J. Neurooncol. 65: 3-13
38. Woerdenbag, H. J., Moskal, T. A., Pras, N., Malingre, T. M., el-Feraly, F. S., Kampinga, H. H., Konings, A. W. (1993) Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells. J. Nat. Prod. 56: 849-856
39. Wykoff, C. C., Beasley, N. J., Watson, P. H., Turner, K. J., Pastorek, J., Sibtain, A., Wilson, G. D., Turley, H., Talks, K. L., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., Harris, A. L. (2000) Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 60: 7075-7083
40. Yamachika, E., Habte, T., Oda, D. (2004) Artemisinin: an alternative treatment for oral squamous cell carcinoma. Anticancer Res. 24: 2153-2160
41. Yoshida, D., Kim, K., Noha, M., Teramoto, A. (2006) Hypoxia inducible factor 1-alpha regulates of platelet derived growth factor-B in human glioblastoma cells. J. Neurooncol. 76: 13-21